Dissolution Incompatibility of Paracetamol as a Silent Dissolution Retardent Of Concomitantly Administered Drugs

dc.contributor.authorYasarathna, K.
dc.contributor.authorWijesinghe, C.
dc.contributor.authorJayasuriya, B.
dc.contributor.authorPathirana, W.
dc.date.accessioned2018-11-16T05:13:48Z
dc.date.available2018-11-16T05:13:48Z
dc.date.issued2017
dc.description.abstractHigh strength tablets containing 500 mg or more active ingredients could affect the dissolution of concomitantly administered drugs. Dissolution of ten generic solid dosage forms was determined in the presence of sodium bicarbonate and paracetamol, 500 – 2250 mg. In a total of 111 dissolution tests 41 failed (37%) to meet the criteria. Where paracetamol was present 36 out of 50 end points failed (72%) with an extreme case in diltiazem tablets with 0% dissolution. Since longest test end points with failures mostly range from 60 – 90 minutes it is advisable to administer paracetamol 1.5 hours after other drugs in order to avoid potential pharmacokinetic disturbances.en_US
dc.identifier.citationPathirana, et al. ,"Dissolution Incompatibility of Paracetamol as a Silent Dissolution Retardent Of Concomitantly Administered Drugs", Int J Pharm 2017; 7(1): 38-49en_US
dc.identifier.issn2249-1848
dc.identifier.urihttp://dr.lib.sjp.ac.lk/handle/123456789/7508
dc.language.isoenen_US
dc.subjectDissolution incompatibility, paracetamol, sodium bicarbonate, diltiazem.en_US
dc.titleDissolution Incompatibility of Paracetamol as a Silent Dissolution Retardent Of Concomitantly Administered Drugsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Dissolution Incompatibility of Paracetamol as a Silent Dissolution Retardent Of Concomitantly Administered Drugs.pdf
Size:
304.67 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections